Characterization and antigenicity of the promising vaccine candidate Plasmodium vivax 34 kDa rhoptry antigen (Pv34)

Alvaro Mongui, Diana I. Angel, Gina Gallego, Claudia Reyes, Paola Martinez, Felipe Guhl, Manuel A. Patarroyo

Producción científica: Contribución a una revistaArtículo de Investigaciónrevisión exhaustiva

15 Citas (Scopus)

Resumen

This study describes the identification of the Plasmodium vivax rhoptry antigen Pv34 whose sequence was obtained based on homology comparison with the Plasmodium falciparum Pf34. The pv34 gene product was characterized by molecular biology and immunological techniques. Additionally, association of Pv34 to detergent-resistant microdomains (DRMs), expression in late blood-stage parasites and recognition of recombinant Pv34 (rPv34) by sera from P. vivax-infected Aotus monkeys and patients was assessed. Lymphoproliferation and cytokine secretion was also evaluated in individuals living in malaria endemic areas. Altogether, the data support carrying out further studies to assess the immunogenicity and protection-inducing ability of rPv34 as component of a multi-antigenic, multi-stage vaccine against vivax malaria.

Idioma originalInglés estadounidense
Páginas (desde-hasta)415-421
Número de páginas7
PublicaciónVaccine
Volumen28
N.º2
DOI
EstadoPublicada - dic. 11 2009

Áreas temáticas de ASJC Scopus

  • Medicina molecular
  • Inmunología y Microbiología General
  • Veterinaria General
  • Salud pública, medioambiental y laboral
  • Enfermedades infecciosas

Huella

Profundice en los temas de investigación de 'Characterization and antigenicity of the promising vaccine candidate Plasmodium vivax 34 kDa rhoptry antigen (Pv34)'. En conjunto forman una huella única.

Citar esto